Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Yellow fever: an update.

¹Acambis Inc, Cambridge, Massachusetts 02139, USA. thomas.monath@acambis.com

The Lancet. Infectious Diseases

|March 2, 2002

Summary

This summary is machine-generated.

Yellow fever remains a significant threat, causing severe illness and death globally. Routine childhood vaccination with the yellow fever 17D vaccine is crucial for disease control and prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Yellow fever as an endemic/epidemic disease and priorities for vaccination.

Bulletin de la Societe de pathologie exotique (1990)·2007

Same author

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

Journal of virology·2004

Same author

Challenge model for Helicobacter pylori infection in human volunteers.

Gut·2004

Same author

Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes.

Medical and veterinary entomology·2003

Same author

West Nile virus vaccine.

Current drug targets. Infectious disorders·2002

Same author

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.

Gut·2002

Same journal

Cefiderocol heteroresistance in NDM Enterobacterales.

The Lancet. Infectious diseases·2026

Same journal

Correction to Lancet Infect Dis 2020; 20: 37-59.

The Lancet. Infectious diseases·2026

Same journal

Correction to Lancet Infect Dis 2020; 20: 60-79.

The Lancet. Infectious diseases·2026

Same journal

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026

Same journal

The Bundibugyo virus disease outbreak: a warning signal for risks to health workers.

The Lancet. Infectious diseases·2026

Same journal

Trials of medical countermeasures to begin in DR Congo.

The Lancet. Infectious diseases·2026

See all related articles

Area of Science:

* Virology
* Epidemiology
* Immunology

Background:

* Yellow fever, a viral hemorrhagic fever, historically caused significant mortality before vaccine development.
* It continues to affect approximately 200,000 individuals annually in tropical Africa and South America, posing risks to unvaccinated travelers.
* Increased urban mosquito vector populations (Aedes aegypti) and air travel heighten the risk of global spread.

Purpose of the Study:

* To review the clinical manifestations, pathogenesis, and pathophysiology of yellow fever.
* To emphasize the critical role of preventative vaccination due to the lack of specific treatments.
* To discuss the efficacy and application of the yellow fever 17D vaccine and its potential as a vector for novel vaccines.

Main Methods:

Related Experiment Videos

* Literature review of clinical features, pathogenesis, and pathophysiology.
* Analysis of epidemiological data on disease incidence and spread.
* Evaluation of the yellow fever 17D vaccine's characteristics, safety, and efficacy.

Main Results:

* Yellow fever presents significant clinical challenges with poorly understood disease mechanisms.
* Preventative vaccination is the primary strategy for managing yellow fever.
* The yellow fever 17D vaccine is safe and effective, with potential for developing new vaccines.

Conclusions:

* Yellow fever, a zoonotic disease, cannot be eradicated but its burden can be reduced through vaccination.
* Routine childhood immunization in endemic areas offers a cost-effective public health benefit.
* The yellow fever 17D virus shows promise as a vector for developing vaccines against other diseases and cancers.